Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    (NCCAM) [SPONSOR-COLLABORATORS] (escitalopram) [TREATMENT]
Show Display Options
Rank Status Study
1 Completed PUFA Augmentation in Treatment of Major Depression
Condition: Major Depression
Interventions: Drug: Polyunsaturated Fatty Acids (PUFA);   Drug: Citalopram
2 Completed
Has Results
MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women
Conditions: Hot Flashes;   Menopause;   Vasomotor Symptoms
Interventions: Drug: Escitalopram;   Other: Placebo
3 Completed
Has Results
Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
Condition: Depression
Interventions: Drug: S-adenosyl-l-methionine;   Drug: Escitalopram;   Drug: Placebo
4 Suspended Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
Condition: Depression
Interventions: Drug: venlafaxine (Effexor);   Drug: duloxetine (Cymbalta);   Drug: escitalopram (Lexapro);   Other: placebo
5 Completed SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
Conditions: Parkinson's Disease;   Depression
Interventions: Drug: SAM-e;   Drug: oral citalopram;   Drug: placebo
6 Completed Drug Therapy to Treat Minor Depression
Condition: Depression
Interventions: Drug: Citalopram;   Drug: St. John's Wort

Indicates status has not been verified in more than two years